Day: August 22, 2024

SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Management will be hosting a fireside chat on Wednesday, September 4, 2024, at 10:45 a.m. Eastern Time / 7:45 a.m. Pacific Time. Investors interested in listening to the conference call may do so by registering at this link: https://url.us.m.mimecastprotect.com/s/r-x6CjRnDNsnPR3wF7sxumTszz?domain=cc.webcasts.com. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event. About SI-BONE, Inc. SI-BONE...

Clarke brings global, executive leadership and a deep connection to consumers around the world NEW ALBANY, Ohio, Aug. 22, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF), a leading, global omnichannel specialty retailer of apparel and accessories, today announced the election of Andrew Clarke to its Board of Directors, effective August 21, 2024. Mr. Clarke, 51, is the Global President of Mars Snacking, a division of Mars, Incorporated. In this role, which he has held since 2018, Clarke is responsible for overseeing one of the world’s most iconic portfolio of snack brands, which represents a significant portion of Mars’ total business. He has more than 30 years in consumer-focused industries, with the last 24 years at Mars in roles of increasing responsibility. Clarke started with Mars in UK sales, before moving...

WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on Thursday, August 29, 2024. Kane Biotech management will host a conference call at 4:30 p.m. ET on August 29, 2024 to review the financial results and discuss business developments in the period. Participants must register for the call using this link: It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A webcast of the call will be available on Kane Biotech’s website at www.kanebiotech.com in the Investor section at ir.kanebiotech.com. About Kane Biotech Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent...

DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that the Company will participate at the H.C. Wainwright 26th Annual Global Investment Conference in New York City. The Company’s presentation by Sean Brynjelsen, Chief Executive Officer, will be available on demand commencing on September 9, 2024, at 7am ET. Investors can access the presentation here. To schedule an in-person 1×1 meeting with the Company, please contact Corporate Access at H.C. Wainwright. About Eton Pharmaceuticals Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has five commercial...

FORT WORTH, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that Steve Gray will retire from his position on Range’s Board of Directors, effective October 1, 2024. Range Chairman, Greg Maxwell stated, “We want to express our gratitude to Steve for his dedicated service to Range. Since joining our Board in 2018, Steve has shared his wisdom, industry experience and expertise, helping Range to become a more resilient and efficient Marcellus operator capable of generating free cash flow and returns of capital through price cycles. We wish Steve and his family the best in his retirement.” Steve Gray commented, “During my time on the Range Board, I have seen the Company navigate through tough times, volatile commodity prices, and a pandemic, yet emerge as a stronger company. I am proud...

Posters to be presented highlight clinical study designs investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuria SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present two posters in classical homocystinuria (HCU) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) annual symposium in Porto, Portugal, September 3-6, 2024. At SSIEM, the Company will present the trial designs of the pivotal Phase 3 HARMONY Study and ENSEMBLE long-term extension study of pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of classical HCU. Additionally, the Company will share the trial design of cohort 7 in the Phase 1/2 COMPOSE Study of pegtibatinase in pediatric participants...

PACE Program Provides Highly Coordinated Personalized Senior Care in Partnership with Eskaton and Adventist Health In a release issued under the same headline on Friday, August 16, 2024, by InnovAge, please note the staff count four years ago has been corrected from seven to 20 people. The revised release is as follows: SACRAMENTO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrated the fourth anniversary of its Sacramento, California center with community members, local representatives, businesses, healthcare providers, and other valued partners. “The demand for affordable, reliable healthcare for seniors is...

ATLANTA, Aug. 22, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, is now offering a limited number of quick move-in and move-in ready homes at Highlands at Vinings, a luxury new home community featuring four-story townhomes with private elevators in each residence and sought-after rooftop terraces in Atlanta, Georgia. The community is located at 2741 Wynberry Lane in the vibrant downtown Vinings area of Atlanta. Brand new, move-in ready townhomes in the community are now available starting at $925,000. Highlands at Vinings is a gated community of just 31 luxury townhomes currently offering home designs with up to 3,553 square feet of living space with 3 bedrooms, 4.5 baths, and 2-car garages. The home designs combine sophisticated living with modern architecture and quality...